Neil Dahiya

Mindset Medical has announced the successful acquisition of FDA 510(k) clearance for its innovative contactless pulse monitoring tool, the IVC application. This marks the company’s inaugural FDA clearance, occurring after a Series A funding round completed earlier this year for […]

Zimmer Biomet (NYSE: ZBH) recently announced its new approval from the FDA for their OsseoFit stemless shoulder system meant for total shoulder arthroplasty. Situated in Warsaw, Indiana, Zimmer Biomet crafted this implant to match the humeral bone’s natural contour. The

Sensome has shared promising results from two recent studies assessing its innovative Clotlid smart guidewire system designed to detect blood clots. The findings emphasize Clotlid’s capability in accurately recognizing “fresh” thrombus — rich in red blood cells (RBCs) — specifically

Medtronic (NYSE: MDT) has revealed the completion of its initial patient procedure using the advanced PillCam Genius SB capsule endoscopy kit. The University of Miami Health System (UHealth) has marked a significant milestone by successfully executing this first ingestion with

Beacon Biosignals has unveiled groundbreaking findings that bolster the efficacy of its EEG headband for sleep analysis. Based in Boston, the company developed the Dreem 3S headband, equipped with machine-learning capabilities. This sophisticated wearable includes six electrodes and an inbuilt

Vantis Vascular announced today the successful closure of its Series B-1 preferred funding round, securing $10 million. Based in San Jose, California, Vantis’ recent fundraising efforts bring its total capital to $30 million. The company focuses on developing the CrossFast

Former employees of Smith+Nephew (NYSE:SNN) claim that the company’s recent layoffs have gone beyond the official announcements. MassDevice first reported that Watford, England-based Smith+Nephew’s orthopedics unit faced layoffs this month, highlighting approximately 150 job cuts in Memphis, Tennessee. However, workers

InspireMD disclosed today that Craig Shore, the company’s Chief Financial Officer, has chosen to retire once his successor is identified and appointed. Shore plans to maintain his role as CFO until the stroke prevention firm selects his replacement, ensuring a

Philips (NYSE: PHG) announced today it has reinforced its strategic alliance with Sim&Cure. Known for their cutting-edge digital approaches in neurovascular therapies, Sim&Cure initially partnered with Philips, which is based in Amsterdam, five years ago. Now, they are embarking on

Johnson & Johnson MedTech has announced an important milestone: the FDA has extended approval for use of Impella heart pumps in treating certain pediatric patients. The approval expansion includes the use of the Impella 5.5 with SmartAssist and the Impella